Aller au contenu principal
Accès ouvert déclaré 2025 article

High fructose levels inhibit the proliferation of cardiomyocytes via the Notch1 signaling pathway

0Citations signalées, ce qui n’est pas une note de qualité
5Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Fructose, as a natural and simple sugar, is not significantly harmful to the human body when consumed in moderation and can provide energy for the body. High-fructose diets have been linked to an increased risk of a range of metabolic disorders, including hypertriglyceridemia, hypertension, and diabetes mellitus. These conditions are known to be associated with an elevated risk of developing cardiometabolic diseases. Cardiomyocytes in mammals possess the capacity to proliferate from the moment of their birth. However, this capacity diminishes over time, and cardiac growth is ultimately achieved through cardiomyocyte (CM) hypertrophy. Prior studies have demonstrated that fructose metabolism is enhanced in the heart during pathological hypertrophy [1]. The consumption of foods containing high levels of fructose has been linked to an increase in the size of cardiomyocytes, which can lead to damage to the heart. The impact of high fructose on cardiomyocytes at the point of their initial capacity for proliferation has not been previously documented. In this experiment, our purpose was to explore the impact of high fructose in cardiomyocyte proliferation. To establish an apical resection model in neonatal mice, neonatal ICR mice were randomly divided into a sham-operated group (Sham + PBS), a sham-operated combined high-fructose group (Sham + fructose), an apical resection alone group (AR + PBS) and an apical resection combined with a high-fructose group (AR + fructose). Next, echocardiography was employed to assess the cardiac function of all mice. Masson staining was carried out to analyze cardiac fibrosis. Immunostaining was performed by extracting primary rat cardiomyocytes after the high-fructose intervention to see if proliferation-related markers (Ki67, PH3, Aurora-B) changed, qRT-PCR and immunofluorescence were used to determine changes in the expression profile of Notch1 in the neonatal heart. The results suggest that high fructose could inhibit cardiomyocyte proliferation in vivo and in vitro, The possible mechanism is that high fructose levels inhibit cardiomyocyte proliferation through suppression of Notch1 signaling pathway. In conclusion, high fructose levels inhibit the proliferation of cardiomyocytes via the Notch1 signaling pathway.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
High fructose levels inhibit the proliferation of cardiomyocytes via the Notch1 signaling pathway
Date Crossref
01/03/2025
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Diet, Metabolism, and DiseaseCongenital heart defects researchLiver Disease Diagnosis and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.